Investigating When Patients With Multiple Sclerosis Should Switch From a Low- or Moderate-Efficacy Therapy to a High-Efficacy Treatment. Bourdette D. Neurology 2024;103:e209835.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bourdette D. Investigating When Patients With Multiple Sclerosis Should Switch From a Low- or Moderate-Efficacy Therapy to a High-Efficacy Treatment. Neurology 2024;103:e209835.
PMID: 39197112